ROYAL BANK OF CANADA - WEREWOLF THERAPEUTICS INC ownership

WEREWOLF THERAPEUTICS INC's ticker is HOWL and the CUSIP is 95075A107. A total of 51 filers reported holding WEREWOLF THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 1.2%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of WEREWOLF THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,000335
+16650.0%
0.00%
Q1 2023$020.0%0.00%
Q4 2022$0
-100.0%
2
-99.5%
0.00%
Q3 2022$2,000
+100.0%
387
+66.1%
0.00%
Q2 2022$1,000
-85.7%
233
-85.6%
0.00%
Q1 2022$7,000
-89.7%
1,622
-71.4%
0.00%
Q4 2021$68,000
+385.7%
5,680
+613.6%
0.00%
Q3 2021$14,000
+55.6%
796
+53.4%
0.00%
Q2 2021$9,0005190.00%
Other shareholders
WEREWOLF THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
DC Funds, LP 589,102$1,796,76138.27%
MPM ASSET MANAGEMENT LLC 4,284,172$13,066,7256.41%
MPM BioImpact LLC 2,388,011$7,283,4341.47%
RA Capital Management 6,144,881$18,741,8870.35%
SPHERA FUNDS MANAGEMENT LTD. 626,810$1,911,7710.30%
PFM Health Sciences, LP 2,303,891$7,026,8680.27%
Rubric Capital Management LP 1,935,357$5,902,8390.25%
Alyeska Investment Group, L.P. 397,808$1,213,3140.01%
Laurion Capital Management LP 522,900$1,594,8450.01%
Schonfeld Strategic Advisors LLC 326,702$996,4410.01%
View complete list of WEREWOLF THERAPEUTICS INC shareholders